Lon protease: A key enzyme controlling mitochondrial bioenergetics in cancer

Molecular and Cellular Oncology

Volumn 1, Issue 4, 2014, Pages

  Quirós, Pedro M ^a   Bárcena, Clea ^a   López Otín, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

aging; cancer; degradome; mitochondrial quality control; OXPHOS

Indexed keywords

EID: 85019028850     PISSN: None     EISSN: 23723556     Source Type: Journal    
DOI: 10.4161/23723548.2014.968505     Document Type: Article

References (10)

1. Venkatesh S, Lee J, Singh K, Lee I, Suzuki CK. Multitasking in the mitochondrion by the ATP-dependent Lon protease. Biochim Biophys Acta 2012; 1823:56-66; PMID:22119779; http://dx.doi.org/10.1016/j.bbamcr.2011.11.003
2. Lu B, Lee J, Nie X, Li M, Morozov YI, Venkatesh S, Bogenhagen DF, Temiakov D, Suzuki CK. Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease. Mol Cell 2013; 49:121-32; PMID:23201127
3. Quiros PM, Espanol Y, Acin-Perez R, Rodriguez F, Barcena C, Watanabe K, Calvo E, Loureiro M, Fernandez-Garcia MS, Fueyo A, et al. ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity. Cell Rep 2014; 8:542-56; PMID:25017063; http://dx.doi.org/10.1016/j.celrep.2014.06.018
4. Erjavec N, Bayot A, Gareil M, Camougrand N, Nystrom T, Friguet B, Bulteau AL. Deletion of the mitochondrial Pim1/Lon protease in yeast results in accelerated aging and impairment of the proteasome. Free Radic Biol Med 2013; 56:9-16; PMID:23220263; http://dx.doi.org/10.1016/j.freeradbiomed.2012.11.019
5. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013; 153:1194-217; PMID:23746838; http://dx.doi.org/10.1016/j.cell.2013.05.039
6. Bernstein SH, Venkatesh S, Li M, Lee J, Lu B, Hilchey SP, Morse KM, Metcalfe HM, Skalska J, Andreeff M, et al. The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives. Blood 2012; 119:3321-9; PMID:22323447; http://dx.doi.org/10.1182/blood-2011-02-340075
7. Bota DA, Davies KJ. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol 2002; 4:674-80; PMID:12198491; http://dx.doi.org/10.1038/ncb836
8. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
9. Lapuente-Brun E, Moreno-Loshuertos R, Acin-Perez R, Latorre-Pellicer A, Colas C, Balsa E, Perales-Clemente E, Quiros PM, Calvo E, Rodriguez-Hernandez MA, et al. Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science 2013; 340:1567-70; PMID:23812712; http://dx.doi.org/10.1126/science.1230381
10. Guha M, Avadhani NG. Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion 2013; 13:577-91; PMID:24004957; http://dx.doi.org/10.1016/j.mito.2013.08.007